Stay updated with breaking news from வேட் கூப்பர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Impel NeuroPharma Announces Second Quarter 2021 Financial globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Impel NeuroPharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Impel NeuroPharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Impel NeuroPharma to Host Virtual Key Opinion Leader Event on August 6, 2021 July 29, 2021 08:00 ET | Source: Impel NeuroPharma Impel NeuroPharma Seattle, Washington, UNITED STATES SEATTLE, July 29, 2021 (GLOBE NEWSWIRE) Impel NeuroPharma, Inc. (NASDAQ: IMPL), a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) diseases with high unmet medical needs, today announced that it will host a virtual key opinion leader (KOL) event to review the post triptan failure landscape and new options for the treatment of acute migraine. In addition, the program will cover the role of non-oral acute migraine therapies, including the history of use of dihydroergotamine (DHE), the STOP301 trial results for Impel’s lead product candidate TRUDHESA™ and commercial insights and opportunities in the acute migra ....
Impel NeuroPharma to Host Virt - GuruFocus.com gurufocus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gurufocus.com Daily Mail and Mail on Sunday newspapers.